INTERCEPT Pathogen Reduced Red Blood Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INTERCEPT Pathogen Reduced Red Blood Cells, covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs [Phase 2]